ATE141601T1 - 3-(1-substituierte pyrazoyl)-2-oxindolderivate - Google Patents
3-(1-substituierte pyrazoyl)-2-oxindolderivateInfo
- Publication number
- ATE141601T1 ATE141601T1 AT91913692T AT91913692T ATE141601T1 AT E141601 T1 ATE141601 T1 AT E141601T1 AT 91913692 T AT91913692 T AT 91913692T AT 91913692 T AT91913692 T AT 91913692T AT E141601 T1 ATE141601 T1 AT E141601T1
- Authority
- AT
- Austria
- Prior art keywords
- pyrazoyl
- substituted
- biosynthesis
- interleukin
- oxindole derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/557,265 US5064851A (en) | 1990-07-24 | 1990-07-24 | 3-(1-substituted-pyrazoyl)-2-oxindole derivatives, compositions and use |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE141601T1 true ATE141601T1 (de) | 1996-09-15 |
Family
ID=24224706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT91913692T ATE141601T1 (de) | 1990-07-24 | 1991-06-12 | 3-(1-substituierte pyrazoyl)-2-oxindolderivate |
Country Status (13)
Country | Link |
---|---|
US (1) | US5064851A (de) |
EP (1) | EP0540614B1 (de) |
JP (1) | JP2504659B2 (de) |
AT (1) | ATE141601T1 (de) |
CA (1) | CA2086432C (de) |
DE (1) | DE69121571T2 (de) |
DK (1) | DK0540614T3 (de) |
ES (1) | ES2090345T3 (de) |
FI (1) | FI107609B (de) |
GR (1) | GR3021291T3 (de) |
IE (1) | IE74689B1 (de) |
PT (1) | PT98404B (de) |
WO (1) | WO1992001684A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5698399A (en) * | 1996-04-05 | 1997-12-16 | Duff; Gordon W. | Detecting genetic predisposition for osteoporosis |
ID21775A (id) * | 1996-10-25 | 1999-07-22 | Yoshitomi Pharmaceutical | Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya |
EP1270565B1 (de) * | 1997-01-29 | 2004-06-30 | Pfizer Inc. | 4-Substituiertes Furan-2-sulfonamid und dessen Verwendung in der Herstellung von Sulfonylharnstoff-Derivate |
CZ293173B6 (cs) * | 1997-01-29 | 2004-02-18 | Pfizer Inc. | Deriváty sulfonylmočoviny |
WO1999051580A1 (en) * | 1998-04-08 | 1999-10-14 | Abbott Laboratories | Pyrazole inhibitors of cytokine production |
AU2001225416A1 (en) * | 2000-01-20 | 2001-07-31 | Nortel Networks Limited | Adaptive frame structures for hybrid cdma/tdma system |
NZ624963A (en) | 2009-04-29 | 2016-07-29 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3259622A (en) * | 1962-09-07 | 1966-07-05 | Merck & Co Inc | 1-benzyl-3-indolyl-alpha-haloalkyl and alkylidenyl acetic acids |
DE3310891A1 (de) * | 1983-03-25 | 1984-09-27 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue indolinon-(2)-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und zwischenprodukte |
US4556672A (en) * | 1984-03-19 | 1985-12-03 | Pfizer Inc. | 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents |
US4569942A (en) * | 1984-05-04 | 1986-02-11 | Pfizer Inc. | N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents |
US4861794A (en) * | 1988-04-13 | 1989-08-29 | Pfizer Inc. | 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis |
US5047554A (en) * | 1989-04-18 | 1991-09-10 | Pfizer Inc. | 3-substituted-2-oxindole derivatives |
-
1990
- 1990-07-24 US US07/557,265 patent/US5064851A/en not_active Expired - Lifetime
-
1991
- 1991-06-12 WO PCT/US1991/004043 patent/WO1992001684A1/en active IP Right Grant
- 1991-06-12 AT AT91913692T patent/ATE141601T1/de not_active IP Right Cessation
- 1991-06-12 DK DK91913692.9T patent/DK0540614T3/da active
- 1991-06-12 EP EP91913692A patent/EP0540614B1/de not_active Expired - Lifetime
- 1991-06-12 JP JP3513041A patent/JP2504659B2/ja not_active Expired - Fee Related
- 1991-06-12 ES ES91913692T patent/ES2090345T3/es not_active Expired - Lifetime
- 1991-06-12 CA CA002086432A patent/CA2086432C/en not_active Expired - Fee Related
- 1991-06-12 DE DE69121571T patent/DE69121571T2/de not_active Expired - Fee Related
- 1991-07-22 PT PT98404A patent/PT98404B/pt not_active IP Right Cessation
- 1991-07-23 IE IE257491A patent/IE74689B1/en not_active IP Right Cessation
-
1993
- 1993-01-22 FI FI930263A patent/FI107609B/fi not_active IP Right Cessation
-
1996
- 1996-10-09 GR GR960402662T patent/GR3021291T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
GR3021291T3 (en) | 1997-01-31 |
IE912574A1 (en) | 1992-01-29 |
PT98404B (pt) | 1999-01-29 |
ES2090345T3 (es) | 1996-10-16 |
EP0540614A1 (de) | 1993-05-12 |
CA2086432A1 (en) | 1992-01-25 |
DE69121571D1 (de) | 1996-09-26 |
IE74689B1 (en) | 1997-07-30 |
PT98404A (pt) | 1992-05-29 |
JP2504659B2 (ja) | 1996-06-05 |
CA2086432C (en) | 1997-12-16 |
EP0540614B1 (de) | 1996-08-21 |
WO1992001684A1 (en) | 1992-02-06 |
DK0540614T3 (da) | 1996-09-09 |
DE69121571T2 (de) | 1997-01-09 |
FI930263A0 (fi) | 1993-01-22 |
US5064851A (en) | 1991-11-12 |
FI107609B (fi) | 2001-09-14 |
JPH05504773A (ja) | 1993-07-22 |
FI930263A (fi) | 1993-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG91773A (bg) | Заместени на трето място производни на 2-оксиндола | |
MXPA03011681A (es) | Uso de inhibidores de epoxido hidrolasa soluble, para tratar enfermedades relacionadas con la enfermedad cardiovascular. | |
EA200000358A1 (ru) | Способ получения диарилпиридинов, полезных в качестве ингибиторов cox-2 | |
IL154710A0 (en) | Isoxazole derivatives and pharmaceutical compositions containing the same | |
AP2003002824A0 (en) | Gyrase inhibitors and uses thereof | |
MXPA04000328A (es) | Derivados de alfa-hidroxiamida estatina para tratamiento de enfermedad de alzheimer. | |
ES8205789A1 (es) | Un procedimiento para la preparacion de derivados del indol | |
ATE177420T1 (de) | Cyclobutan-derivate als inhibitoren der squalen- synthetase und der protein-farnesyltransferase | |
NO20051100L (no) | Pyrazolsammensetninger anvendelige som GSK-3-inhibitorer | |
NO20083411L (no) | Indaneddiksyrederivater og deres anvendelse som farmasoytiske midler, intermediater og fremgangsmater for fremstilling | |
ES2058292T3 (es) | Derivados de indol. | |
NZ312840A (en) | Ketoheterocyclic inhibitors of factor Xa | |
MXPA03011954A (es) | Nuevos derivados de acido sulfonico. | |
MXPA02011858A (es) | Inhibidores de adhesion de celula mediada por alfabeta2. | |
ATE141601T1 (de) | 3-(1-substituierte pyrazoyl)-2-oxindolderivate | |
ATE223376T1 (de) | Bisarylcyclobutenderivate als cyclooxygenasehemmer | |
EE9800230A (et) | Difenüülstilbeenid kui COX-2 inhibiitorite eelravimid | |
CY1108187T1 (el) | Μεθοδος για την παρασκευη παραγωγων της (3-οξο 2,3-διυδρο-1η-ισοϊνδολ-1-υλο)-ακετυλογουανιδινης | |
HK1050141A1 (en) | Inhibitor for 20-hete-yielding enzyme | |
NO994049L (no) | Metode for aa fremstille farmasöytiske forbindelser | |
PT1276722E (pt) | Inibidores de naftamidina-uroquinase | |
NZ336042A (en) | Farnesyl transferase inhibitors | |
NO924806L (no) | Etanoladdukter av 6-sulfonylsubstituerte 3-hydroksykromaner og deres anvendelse som inhalasjonsmiddel ved sykdommer | |
EE200100663A (et) | Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks | |
GEP20022799B (en) | ) Intermediates for Making HIV-Protease Inhibitors and Methods of Making HIV- Protease Inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |